Evidence map›Paper›PMID 33163957›Full record

ArticleToxicon: X2020

Partial proteomic analysis of brown widow spider (

Pornsawan Khamtorn, Prapenpuksiri Rungsa, Nisachon Jangpromma, Sompong Klaynongsruang, Jureerut Daduang, Thanee Tessiri, Sakda Daduang

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Toxicon: X, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. International journal of molecular sciences · 2026
    Article
  2. Paralysis efficiency (PDToxicon: X · 2026
    Article
  3. Review
  4. Article
  5. Venomics of ScorpionToxins · 2024
    Article
  6. Article
  7. Overview of protein posttranslational modifications in Arthropoda venoms.The journal of venomous animals and toxins including tropical diseases · 2022
    Review
  8. De Novo Transcriptome Analysis of the Venom ofMolecules (Basel, Switzerland) · 2021
    Article
  9. Article
  10. Widow spiders in the New World: a review onThe journal of venomous animals and toxins including tropical diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Pornsawan KhamtornFaculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Prapenpuksiri RungsaFaculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Nisachon JangprommaProtein and Proteomics Research Center for Commercial and Industrial Purposes (ProCCI), Khon Kaen University, Khon Kaen, 40002, Thailand.
Sompong KlaynongsruangProtein and Proteomics Research Center for Commercial and Industrial Purposes (ProCCI), Khon Kaen University, Khon Kaen, 40002, Thailand.
Jureerut DaduangDepartment of Clinical Chemistry, Faculty of Associated Medical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Thanee TessiriFaculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, 40002, Thailand.
Sakda DaduangProtein and Proteomics Research Center for Commercial and Industrial Purposes (ProCCI), Khon Kaen University, Khon Kaen, 40002, Thailand.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Spiders use their venom for defence and to capture prey. These venoms contain a cocktail of biologically active compounds that display several different biological activities, such as large molecules and small molecules including peptides, proteins/enzymes, and other components. Thus, venom constituents have attracted the attention of biochemists and pharmacologists over the years. The brown widow spider (

Indexed as

Antibacterial activityBWSV, brown widow spider venomHyaluronidasekDa, kilodaltonLatrodectus geometricusLC-MS/MS, liquid chromatography–mass spectrometry/mass spectrometryOD600, optical density at 600 nmPD50, 50% paralytic doseToxicityVenomWidow spiderα-latrocrustotoxin, alpha-latrocrustotoxinα-, β-, γ-, δ-, ε-LIT, alpha-, beta-, gramma-, delta-, epsilon-latroinsectotoxins

Identifiers

PMID33163957
PMCPMC7607507

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.